Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jugesh Chhatwal

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Human Vaccines & Immunotherapeutics|August 21, 2015
Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trialAnand Prakash Dubey, Sharad Agarkhedkar, Jugesh Chhatwal, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2014
Randomized, open-label study of the impact of age on booster responses to the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in children in IndiaSanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled studySanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, et al.
Vaccine|August 9, 2021
A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in IndiaJugesh Chhatwal, Amita Sapru, Balasubramanian Sundaram, et al.
Human Vaccines & Immunotherapeutics|February 15, 2019
Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in IndiaSharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, et al.
International Journal of Applied & Basic Medical Research|June 27, 2022
Stages of Concern of Medical Faculty toward Adoption of Competency-based Medical Education in India: A Multicentric SurveyRajiv Mahajan, Amrit Virk, Shaista Saiyad, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in IndiaYeshwant K Amdekar, Sanjay K Lalwani, Ashish Bavdekar, et al.
The Clinical Respiratory Journal|September 25, 2016
Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associated factors in childrenSheetu Singh, Bharat Bhushan Sharma, Sundeep Salvi, et al.
Human Vaccines & Immunotherapeutics|November 19, 2015
Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infantsDulari J Gandhi, Sangappa M Dhaded, Mandyam D Ravi, et al.
Indian Pediatrics|December 13, 2023
Indian Academy of Pediatrics Revised Guidelines on Evaluation, Prevention and Management of Childhood ObesityVaman Khadilkar, Nikhil Shah, Rekha Harish, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Human Vaccines & Immunotherapeutics|August 21, 2015
Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trialAnand Prakash Dubey, Sharad Agarkhedkar, Jugesh Chhatwal, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2014
Randomized, open-label study of the impact of age on booster responses to the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in children in IndiaSanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: a single-blind, randomized, controlled studySanjay Lalwani, Sukanta Chatterjee, Jugesh Chhatwal, et al.
Vaccine|August 9, 2021
A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in IndiaJugesh Chhatwal, Amita Sapru, Balasubramanian Sundaram, et al.
Human Vaccines & Immunotherapeutics|February 15, 2019
Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in IndiaSharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, et al.
International Journal of Applied & Basic Medical Research|June 27, 2022
Stages of Concern of Medical Faculty toward Adoption of Competency-based Medical Education in India: A Multicentric SurveyRajiv Mahajan, Amrit Virk, Shaista Saiyad, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in IndiaYeshwant K Amdekar, Sanjay K Lalwani, Ashish Bavdekar, et al.
The Clinical Respiratory Journal|September 25, 2016
Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associated factors in childrenSheetu Singh, Bharat Bhushan Sharma, Sundeep Salvi, et al.
Human Vaccines & Immunotherapeutics|November 19, 2015
Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infantsDulari J Gandhi, Sangappa M Dhaded, Mandyam D Ravi, et al.
Indian Pediatrics|December 13, 2023
Indian Academy of Pediatrics Revised Guidelines on Evaluation, Prevention and Management of Childhood ObesityVaman Khadilkar, Nikhil Shah, Rekha Harish, et al.
Pageof 3